Profit Or Loss [Abstract]

ChemoMetec - Filing #1269875

Concept	2023-07-01 to 2024-06-30	2023-07-01 to 2024-06-30	2023-07-01 to 2024-06-30	2023-07-01 to 2024-06-30	2023-07-01 to 2024-06-30	2022-07-01 to 2023-06-30	2022-07-01 to 2023-06-30	2022-07-01 to 2023-06-30	2022-07-01 to 2023-06-30	2022-07-01 to 2023-06-30
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue	—	—	407,350 DKK	—	—	—	—	442,274 DKK	—	—
Other income	—	—	520,000 DKK	—	—	—	—	2,127 DKK	—	—
Other work performed by entity and capitalised	—	—	27,823 DKK	—	—	—	—	27,458 DKK	—	—
Raw materials and consumables used	—	—	68,098 DKK	—	—	—	—	60,359 DKK	—	—
Employee benefits expense	—	—	135,226 DKK	—	—	—	—	115,754 DKK	—	—
Depreciation and amortisation expense	—	—	17,209 DKK	—	—	—	—	20,469 DKK	—	—
Other expenses, by nature	—	—	46,194 DKK	—	—	—	—	44,716 DKK	—	—
Profit (loss) from operating activities	—	—	168,966 DKK	—	—	—	—	230,561 DKK	—	—
Finance income	—	—	8,900 DKK	—	—	—	—	2,516 DKK	—	—
Finance costs	—	—	1,280 DKK	—	—	—	—	2,717 DKK	—	—
Profit (loss) before tax	—	—	176,586 DKK	—	—	—	—	230,360 DKK	—	—
Tax expense (income)	—	—	40,302 DKK	—	—	—	—	51,693 DKK	—	—
Profit (loss)	69,600 DKK	- DKK	136,284 DKK	- DKK	66,684 DKK	104,415 DKK	74,252 DKK	178,667 DKK	- DKK	- DKK
Earnings per share [text block]	—	—	—	—	—	—	—	—	—	—
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share	—	—	783.00	—	—	—	—	1,027.00	—	—
Diluted earnings per share [abstract]
Diluted earnings (loss) per share	—	—	783.00	—	—	—	—	1,027.00	—	—